EA201690227A1 - Азаиндольные соединения, их получение и способы их применения - Google Patents
Азаиндольные соединения, их получение и способы их примененияInfo
- Publication number
- EA201690227A1 EA201690227A1 EA201690227A EA201690227A EA201690227A1 EA 201690227 A1 EA201690227 A1 EA 201690227A1 EA 201690227 A EA201690227 A EA 201690227A EA 201690227 A EA201690227 A EA 201690227A EA 201690227 A1 EA201690227 A1 EA 201690227A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- methods
- azaindol
- production
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Изобретение относится к соединениям формулы (I) и способам лечения микобактериальной инфекции или туберкулеза или ингибирования ими DprE1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3196CH2013 | 2013-07-17 | ||
PCT/US2014/046100 WO2015009525A1 (en) | 2013-07-17 | 2014-07-10 | Azaindole compounds, synthesis thereof, and methods of using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201690227A1 true EA201690227A1 (ru) | 2016-07-29 |
EA028611B1 EA028611B1 (ru) | 2017-12-29 |
Family
ID=51261257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201690227A EA028611B1 (ru) | 2013-07-17 | 2014-07-10 | Азаиндольные соединения, их получение и способы их применения |
Country Status (10)
Country | Link |
---|---|
US (1) | US9163020B2 (ru) |
EP (1) | EP3021947B1 (ru) |
JP (1) | JP6366709B2 (ru) |
KR (1) | KR102301753B1 (ru) |
CN (1) | CN105636646B (ru) |
AU (1) | AU2014290598B2 (ru) |
CA (1) | CA2918487C (ru) |
EA (1) | EA028611B1 (ru) |
ES (1) | ES2644025T3 (ru) |
WO (1) | WO2015009525A1 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201512197A (zh) * | 2013-08-30 | 2015-04-01 | Hoffmann La Roche | 吡咯并吡啶或吡唑并吡啶衍生物 |
GB201317363D0 (en) * | 2013-10-01 | 2013-11-13 | Eisai Ltd | Novel compounds |
EP3720432A4 (en) | 2017-12-06 | 2021-08-25 | Prollergy Corporation | COMPOSITION AND METHOD FOR MITIGATING AN ALLERGIC REACTION |
RU2702224C2 (ru) * | 2018-03-29 | 2019-10-07 | Общество С Ограниченной Ответственностью "Мт-Медикалс" | Производные фенил формамидина, обладающие антимикобактериальной активностью |
KR20210021042A (ko) * | 2018-06-15 | 2021-02-24 | 카딜라 핼쓰캐어 리미티드 | 포유동물 감염 치료를 위한 신규한 화합물 |
WO2020188405A1 (en) * | 2019-03-20 | 2020-09-24 | Foundation For Neglected Disease Research | Benzimidazoles derivatives as anti-tuberculosis agents |
CN111393435A (zh) * | 2020-03-16 | 2020-07-10 | 青岛吉澳医药科技有限公司 | 氮杂吲哚酰胺类化合物及其制备方法和用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1532980A1 (en) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
EA020332B1 (ru) * | 2007-08-10 | 2014-10-30 | Х. Лундбекк А/С | Аналоги гетероариламидов |
SG10201502109VA (en) * | 2010-03-18 | 2015-05-28 | Pasteur Institut Korea | Anti-infective compounds |
-
2014
- 2014-07-10 WO PCT/US2014/046100 patent/WO2015009525A1/en active Application Filing
- 2014-07-10 EP EP14745305.4A patent/EP3021947B1/en active Active
- 2014-07-10 CN CN201480046182.4A patent/CN105636646B/zh active Active
- 2014-07-10 ES ES14745305.4T patent/ES2644025T3/es active Active
- 2014-07-10 US US14/327,784 patent/US9163020B2/en active Active
- 2014-07-10 AU AU2014290598A patent/AU2014290598B2/en active Active
- 2014-07-10 EA EA201690227A patent/EA028611B1/ru unknown
- 2014-07-10 JP JP2016526988A patent/JP6366709B2/ja active Active
- 2014-07-10 KR KR1020167004150A patent/KR102301753B1/ko active IP Right Grant
- 2014-07-10 CA CA2918487A patent/CA2918487C/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR102301753B1 (ko) | 2021-09-15 |
US9163020B2 (en) | 2015-10-20 |
KR20160058757A (ko) | 2016-05-25 |
CA2918487C (en) | 2021-08-03 |
CA2918487A1 (en) | 2015-01-22 |
CN105636646B (zh) | 2017-12-19 |
AU2014290598B2 (en) | 2018-11-08 |
JP2016530242A (ja) | 2016-09-29 |
WO2015009525A1 (en) | 2015-01-22 |
JP6366709B2 (ja) | 2018-08-01 |
ES2644025T3 (es) | 2017-11-27 |
AU2014290598A1 (en) | 2016-02-11 |
EP3021947B1 (en) | 2017-08-23 |
BR112016000712A2 (pt) | 2022-03-22 |
EA028611B1 (ru) | 2017-12-29 |
EP3021947A1 (en) | 2016-05-25 |
CN105636646A (zh) | 2016-06-01 |
US20150025087A1 (en) | 2015-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201792205A1 (ru) | Гетероциклические соединения как ингибиторы lsd1 | |
EA201890204A1 (ru) | Антибактериальные соединения | |
EA201791420A1 (ru) | Соединения триазолопиримидина и их применения | |
EA201792535A1 (ru) | Гетероциклические амиды в качестве ингибиторов киназ | |
EA201990043A1 (ru) | Антибактериальные соединения | |
EA201991197A1 (ru) | БЕНЗИМИДАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ c-Kit | |
EA201692316A1 (ru) | Производные холана для применения при лечении и/или профилактике fxr и tgr5/gpbar1-опосредованных заболеваний | |
EA201692203A1 (ru) | Соединения, ингибирующие tank-связывающую киназу | |
EA201990044A1 (ru) | Гетероциклические соединения в качестве антибактериальных средств | |
CY1122805T1 (el) | Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων | |
EA201690473A1 (ru) | Комбинированный состав двух противовирусных соединений | |
EA201591889A1 (ru) | 6-(5-гидрокси-1h-пиразол-1-ил)никотинамидные ингибиторы phd | |
TR201906366T4 (tr) | Polisiklik-karbamoilpiridon bileşiklerinin sentezi. | |
EA201890239A3 (ru) | Фумараты как пролекарства и их применение при лечении различных заболеваний | |
CR20150470A (es) | Derivados de triazolona de piridinilo y piridinilo fusionado | |
EA201691272A1 (ru) | Тетрагидропиридопиразины в качестве модуляторов gpr6 | |
EA201591728A1 (ru) | Гетероциклические соединения и способы их применения | |
EA201690227A1 (ru) | Азаиндольные соединения, их получение и способы их применения | |
EA201591360A1 (ru) | Азабензимидазолы в качестве ингибиторов изозимов фдэ4 для лечения цнс и других расстройств | |
CR20140468A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
EA201792471A1 (ru) | Бигетероарильные соединения и их применения | |
EA201500801A1 (ru) | Бензохинолоновые ингибиторы vmat2 | |
EA201692521A1 (ru) | Пиразольные соединения и их применение в качестве блокаторов кальциевых каналов т-типа | |
EA201592183A1 (ru) | Ингибиторы bace | |
EA201590552A1 (ru) | Аминохинолины в качестве ингибиторов киназы |